• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD must make a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. There isn't much information on how does medication for adhd work long-term exposure to these drugs can affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological conditions like hearing loss or impaired vision, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Pregnant women who use ADHD medications need to balance the benefits of using them against the risks to the fetus. The doctors don't have the information to provide clear recommendations however they can provide information about risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy were not at higher risk of fetal malformations or structural birth defects. The researchers used a large, population-based case-control study to determine the prevalence of major structural birth defects in babies born to mothers who had taken stimulants during early pregnancy, as well as those who had not. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure an accurate case classification and to limit the possibility of bias.

However, the researchers' study had its limitations. The researchers were not able, in the first place to differentiate the effects of the medication for Adhd and odd (maps.Google.ml) from the disorder. This limitation makes it difficult to determine whether the limited associations observed in the exposed groups are due to medication use or the confounding effect of comorbidities. Researchers also did not examine the long-term effects for the offspring.

The study did show that babies whose mothers had taken ADHD medications during pregnancy were at a slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than those whose mothers had not taken any medication or cut back on their medications prior to or during pregnancy. The reason for this was central nervous system disorders. The higher risk of admission was not influenced by the stimulant medication used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having a caesarean section or the baby was not scoring well on the Apgar scale (less than 7). These increases appear to be unrelated to the type of medication taken during pregnancy.

The research suggests that the small risk associated with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefits to both the mother and child of continued treatment for the woman's condition. Physicians should talk to their patients about this and try to help them develop coping skills that could reduce the impact of her disorder in her daily functioning and her relationships.

Interactions with Medication

As more women than ever are diagnosed with ADHD and treated with medication, the dilemma of whether to continue or end treatment during pregnancy is one that more and more doctors face. The majority of these decisions are taken in the absence of any evidence that is clear and definitive either way, so physicians must weigh their knowledge about their experiences, the experiences of other doctors, and what research suggests about the subject, along with their best judgment for each individual patient.

Particularly, the issue of potential risks for the baby can be tricky. The research on this subject is based on observations rather than controlled studies and many of the findings are in conflict. Most studies restrict their analysis to live births, which can underestimate the teratogenic impact that can lead to abortions or terminations of pregnancy. The study discussed in the journal club addresses these shortcomings by analyzing the data from deceased and live births.

Conclusion Some studies have revealed an association between ADHD medications and certain birth defects however, other studies haven't found a correlation. The majority of studies show a neutral, or even slightly negative, effect. In the end, a careful risk/benefit assessment must be done in each instance.

It can be challenging, if not impossible, for women suffering from ADHD to stop taking their medication. In an article published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of isolation and family conflict for these patients. Additionally, the loss of medication can affect the ability to do jobs and drive safely, which adhd medication is best for me quiz are important aspects of a normal life for many people with ADHD.

She recommends women who are unsure about whether to keep or stop medication in light of their pregnancy consider the possibility of educating friends, family members and colleagues on the condition, its effects on daily life, and the advantages of staying on the current treatment regimen. It can also help a woman feel supported in her decision. It is important to note that certain drugs can be absorbed through the placenta so if a woman decides to discontinue her ADHD medication during pregnancy and breastfeeding, she should be aware of the possibility that traces of the drug can be transferred to the infant.

Birth Defects and Risk of

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns about what impact the medications could have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this subject. Researchers used two massive data sets to examine more than 4.3 million pregnancies and determine whether stimulant medications caused birth defects. While the overall risk remains low, the researchers did find that first-trimester exposure to ADHD medications was linked to a slightly higher rate of specific heart defects, such as ventriculoseptal defect (VSD).

The researchers of the study did not discover any link between the use of early medications and other congenital anomalies like facial deformities or club feet. The results are in line with previous studies that showed an insignificant, but small increase in the number of cardiac malformations among women who started taking ADHD medication prior to the time of pregnancy. The risk grew in the later part of pregnancy, when a lot of women are forced to stop taking their ADHD medications.

Women who took ADHD medications in the first trimester of their pregnancy were also more likely to have a caesarean section, a low Apgar score following delivery, and a baby who needed help breathing at birth. The authors of the study could not remove bias in selection since they limited their study to women with no other medical conditions that might have contributed to the findings.

The researchers hope that their research will help inform the clinical decisions of doctors who encounter pregnant women. They advise that while discussing risks and benefits is important but the decision to stop or continue medication must be based on each woman's needs and the severity of her ADHD symptoms.

The authors also warn that, while stopping the medication is an option, it is not an option to consider due to the high incidence of depression and other mental health problems in women who are pregnant or who are recently postpartum. Additionally, the research suggests that women who choose to stop taking their medication are more likely to experience difficulties getting adhd medication uk used to life without them following the birth of their baby.

Nursing

It can be a stressful experience becoming a mother. Women suffering from ADHD may face a lot of challenges when they must manage their symptoms, attend doctor appointments, prepare for the birth of a child and adjust to new routines. Many women opt to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications are absorbed by breast milk in small quantities, so the risk to the infant who is breastfeeding is low. The rate of medication exposure can vary depending upon the dosage, frequency of administration and time of day. Additionally, different medications enter the infant's system differently through the gastrointestinal tract and breast milk and the impact of this on a newborn isn't yet fully understood.

Due to the absence of research, some doctors may recommend stopping stimulant medication during a woman's pregnancy. It's a difficult choice for the woman who must weigh the advantages of continuing her medication against the risks to the foetus. As long as more information is available, GPs can inquire about pregnant patients if they have a background of ADHD or if they are planning to take medication during the perinatal period.

A increasing number of studies have revealed that most women can safely continue their ADHD medication while they are pregnant and nursing. In the end, more and more patients choose to do so and in consultation with their physician, they have found that the benefits of continuing their current medication exceed any risk.

Women who suffer from ADHD who are planning to nurse should seek advice from a specialist psychiatrist prior to becoming pregnant. They should discuss the medication they are taking with their physician and discuss the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation should also be offered to help pregnant women suffering from ADHD understand their symptoms and the underlying disorder, learn about available treatments and to reinforce existing coping strategies. This should be a multidisciplinary approach with the GP doctors, obstetricians and psychiatrists. The pregnancy counselling should consist of the discussion of a plan for management for both mother and child, and monitoring for signs of deterioration and the need for adjustments to the medication regimen.